Literature DB >> 31295562

Impact of persistent β-lactam allergy documentation despite delabeling in the perioperative setting.

Yara Moussa1, Andrew Sullivan2, Gilbert Matte3, Robert H Goldstein2, Gabriele Baldini4, Joseph Shuster1, Christos Tsoukas5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31295562     DOI： 10.1016/j.jaip.2019.06.029

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

1.  Standardization and Updating of a Drug Allergy Testing Program: The McGill Experience and Impact on Pharmacy Activities.

Authors:  Gilbert Matte; Joseph Shuster; Chantal Guevremont; Phil Gold; Fabrice Leong; Zinquon Ngan; André Bonnici; Chris Tsoukas
Journal:  Can J Hosp Pharm       Date:  2020-02-01

Review 2.  Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations.

Authors:  Karen M Anstey; Lulu Tsao; Iris M Otani
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

Review 3.  Antibiotic Allergy De-Labeling: A Pathway against Antibiotic Resistance.

Authors:  Inmaculada Doña; Marina Labella; Gádor Bogas; Rocío Sáenz de Santa María; María Salas; Adriana Ariza; María José Torres
Journal:  Antibiotics (Basel)       Date:  2022-08-03

Review 4.  Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge: a systematic review.

Authors:  Lesley Cooper; Jenny Harbour; Jacqueline Sneddon; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2021-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.